Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar barryballs (32.17) Submitted: 8/2/2012 9:27:41 AM : Outperform Start Price: $12.50 TRIB Score: +10.14

TECHNICALS

Featured Broker Partners


Advertisement